LIF vs TRAK

For growth investors, Life360, Inc.

(LIF) is the stronger pick with 31. 8% revenue growth year-over-year, versus 10. 5% for ReposiTrak, Inc. (TRAK). Life360, Inc. (LIF) offers the better valuation at 24. 9x trailing P/E (34. 1x forward), making it the more compelling value choice. Analysts rate Life360, Inc. (LIF) a "Buy" — based on 10 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Life360, Inc.

(LIF) is the cheapest at 24. 9x versus ReposiTrak, Inc. at 29. 0x. On forward P/E, ReposiTrak, Inc. is actually cheaper at 27. 8x — notably different from the trailing picture, reflecting expected earnings growth.

By beta (market sensitivity over 5 years), ReposiTrak, Inc.

(TRAK) is the lower-risk stock at 1. 15β versus Life360, Inc. 's 2. 25β — meaning LIF is approximately 95% more volatile than TRAK relative to the S&P 500. On balance sheet safety, ReposiTrak, Inc. (TRAK) carries a lower debt/equity ratio of 1% versus 57% for Life360, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Life360, Inc.

(LIF) is pulling ahead at 31. 8% versus 10. 5% for ReposiTrak, Inc. (TRAK). On earnings-per-share growth, the picture is similar: Life360, Inc. grew EPS 29. 0% year-over-year, compared to 20. 7% for ReposiTrak, Inc.. Over a 3-year CAGR, LIF leads at 28. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

ReposiTrak, Inc.

(TRAK) is the more profitable company, earning 30. 9% net margin versus 30. 8% for Life360, Inc. — meaning it keeps 30. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: TRAK leads at 27. 5% versus 3. 8% for LIF. At the gross margin level — before operating expenses — TRAK leads at 83. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, ReposiTrak, Inc.

(TRAK) trades at 27. 8x forward P/E versus 34. 1x for Life360, Inc. — 6. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for TRAK: 136. 3% to $24. 00.

In this comparison, TRAK (0.

9% yield) pays a dividend. LIF does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, ReposiTrak, Inc.

(TRAK) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 15), 0. 9% yield). Life360, Inc. (LIF) carries a higher beta of 2. 25 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: LIF is a small-cap high-growth stock; TRAK is a small-cap quality compounder stock. TRAK pays a dividend while LIF does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.